Intramuscular injection of bone marrow mononuclear cells (BMMNC) vs control
Increase in PFWD (m) ( · people with CLI who were not suitable for revascularisation and showed no improvement in response to the best standard therapy
1 finding from 1 review
- Local intramuscular transplantation of autologous bone marrow mononuclear cells for critical lower limb ischaemia 2022 · Cochrane Headline outcomes onlyno estimate extracted1 study · 53 participantsLow